title: Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis?
authors.affiliation: Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Berlin.
authors.forename: Elise
authors.initials: E
authors.lastname: Siegert
authors.affiliation: Department of Rheumatology, University Medical Center Schleswig-Holstein, Lübeck, Germany gabriela.riemekasten@uksh.de.
authors.forename: Gabriela
authors.initials: G
authors.lastname: Riemekasten
mesh_terms: D006801:Humans; D007108:Immune Tolerance; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology
chemical_list: D007166:Immunosuppressive Agents